Full Text View
Tabular View
No Study Results Posted
Related Studies
Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis
Expanded access is currently available for this treatment.
Verified July 2012 by University of California, San Francisco
Study NCT00508963   Information provided by University of California, San Francisco

First Received on July 27, 2007.   Last Updated on July 17, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Leishmaniasis, Cutaneous
Leishmaniasis, Mucocutaneous
Additional conditions recognized in this trial
Leishmaniasis
More general conditions related to this trial
Euglenozoa Infections
Parasitic Diseases
Protozoan Infections
Skin Diseases
Skin Diseases, Infectious
Skin Diseases, Parasitic
Interventions listed in this trial
sodium stibogluconate (Pentostam)
Additional drug interventions recognized in this trial
Antimony Sodium Gluconate
More general drug interventions related to this trial
Anthelmintics
Anti-Infective Agents
Antiparasitic Agents
Antiplatyhelmintic Agents
Antiprotozoal Agents
Pharmacologic Actions
Schistosomicides
Therapeutic Uses
Sponsors listed in this trial
University of California, San Francisco


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services